Carmot Therapeutics is a biotech startup that will transform the way drugs are discovered.
Despite many exciting biological advances, the pharmaceutical industry has not been able to find drugs that exploit recent discoveries. Current drug-screening approaches are limited in their ability to access the chemical diversity necessary to identify candidates for new and unusual proteins.
To solve this problem, we have developed a potentially disruptive technology called Chemotype Evolution. Chemotype Evolution can evolve small drug molecules iteratively through successive rounds of screening and selection. Importantly, Chemotype Evolution opens access to vast chemical diversity and allows Carmot to rapidly home in on molecules with unique, superior biological properties. Such molecules would be nearly impossible to find with traditional methods. In addition, Chemotype Evolution is fast, efficient, and applicable to many different diseases.
Carmot is using its technology to discover its own drugs and is also partnering with a few select companies to apply the technology to targets of mutual interest.
Carmot recently closed its first round of venture capital funding and is seeking a logo.